Clinical Genomics partners with the Colorectal Cancer Alliance in the Life After Cancer Mission
November 29, 2018 08:30 ET | Clinical Genomics
BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced its partnership with the...
Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs
November 01, 2018 08:18 ET | Clinical Genomics
Relationship ensures broad access to innovative FIT test in the U.S. BRIDGEWATER, N.J., and SECAUCUS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading innovator of tests for...
Clinical Genomics appoints Betsy Hanna as Chief Commercial Officer
October 26, 2018 08:30 ET | Clinical Genomics
BRIDGEWATER, N.J., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Betsy...
Two new Board of Director appointments to liquid biopsy company Clinical Genomics
October 16, 2018 08:30 ET | Clinical Genomics
BRIDGEWATER, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer testing solutions and liquid biopsy testing, today announced two appointments to the company’s...
Clinical Genomics is proud to support Strides for Life and Super Bowel I
August 24, 2018 09:00 ET | Clinical Genomics
Overcoming the stigma associated with colorectal cancer screening; former NFL players lead the way by undertaking colonoscopy and InSure ONE FIT testing in Super Bowel I BRIDGEWATER, N.J., Aug. 24,...
Clinical Genomics Pathology Inc. receives licensure from State of California Department of Public Health
June 14, 2018 08:30 ET | Clinical Genomics
BRIDGEWATER, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP...
Biotech with Liquid Biopsy for Colorectal Cancer Secures $26 Million in New Funding
June 01, 2018 08:30 ET | Clinical Genomics
Clinical Genomics drives the commercialization of Colvera™, a liquid biopsy test service for colorectal cancer (CRC) recurrence and the focus of growing clinical evidence to support its use as the...
Clinical Genomics Presents Clinical Utility Data for COLVERA™ at 2018 ASCO Annual Meeting
May 24, 2018 08:30 ET | Clinical Genomics
BRIDGEWATER, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer (CRC) testing and solutions, today announced that data demonstrating the utility of...
Clinical Genomics Pathology Inc. receives licensure from Florida Agency for Healthcare Administration
March 06, 2018 08:30 ET | Clinical Genomics
BRIDGEWATER, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP...
Pivotal study reports InSure® FIT™ offers superior sensitivity for colorectal cancer screening
February 01, 2018 08:30 ET | Clinical Genomics
BRIDGEWATER, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, manufacturer of fecal immunochemical tests for colorectal cancer screening programs, announces that in a study of more than...